
Innate Pharma has announced updated efficacy and safety results from the dose-escalation part of the phase 1/2 study with SAR443579/IPH6101 …

Innate Pharma has announced that the first patient has been dosed in its Sanofi-sponsored phase 1/2 clinical trial, which aims …

Innate Pharma has announcedย that the drug jointly researched between itself and Sanofi has received US Food and Drug Administration (FDA) …

Innate Pharma has named Dr Joyson Karakunnel as its new Executive Vice President and Chief Medical Officer (CMO), with current …

Lirilumab, Innate Pharmaโs acute myeloid leukaemia (AML) treatment, has failed to meet its primary end point in a recent Phase …

French firm Innate Pharma has announced that the current-AstraZeneca head of oncology is joining the company as chairman of the …

French firm Innate Pharma has announced that the current-AstraZeneca head of oncology is joining the company as chairman of the …